TransMedics Group Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio59.01
Forward P/E56.70
P/S Ratio4.7410.6621.0817.5821.08
P/B Ratio9.1518.7810.527.845.20
Price/Tangible Book9.7420.9710.527.845.20
Price/OCF42.88
Enterprise Value Ratios
EV/Revenue5.1711.0319.6215.3417.25
EV/EBITDA39.83307.71
EV/EBIT60.825495.72
Profitability & Returns
Return on Equity (ROE)0.19%-0.15%-0.28%-0.51%-0.36%
Return on Assets (ROA)0.03%0.00%-0.10%-0.17%-0.13%
Return on Invested Capital (ROIC)0.11%0.00%-0.86%-2.46%-2.51%
Return on Capital Employed (ROCE)0.05%0.00%-0.12%-0.35%-0.19%
Leverage & Solvency Ratios
Debt/Equity2.273.760.360.650.33
Debt/EBITDA8.1938.35
Liquidity Ratios
Current Ratio8.309.3010.665.1112.36
Quick Ratio7.258.349.674.2311.15
Efficiency Ratios
Asset Turnover0.580.490.450.210.20
Inventory Turnover3.952.701.590.680.78
Yield & Distribution Ratios
Earnings Yield0.02%-0.01%-0.02%-0.08%-0.05%
FCF Yield-0.04%-0.06%-0.03%-0.06%-0.06%
Buyback Yield-0.08%-0.10%-0.07%-0.12%-0.74%